ISPOR Good Practices Reports are highly cited, expert consensus guidance recommendations that set international standards for HEOR and its use in healthcare decision making. Other ISPOR Reports provide guidance on important areas such as applications, HTA and policy, terms and definitions, and reviews. All ISPOR Reports are made freely available as part of the Society’s mission.
ISPOR Report Types
Most Recent
Clinical Outcomes
-
Is IQWiG's 15% Threshold Universally Applicable in Assessing the Clinical Relevance of Patient-Reported Outcomes Changes?
-
Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness
-
Clinician-Reported Outcome Assessments of Treatment Benefit-Clinical Outcome Assessment Emerging Good Practices Task Force
Economic Evaluation
Epidemiology & Public Health
Health Policy & Regulatory
-
Is IQWiG's 15% Threshold Universally Applicable in Assessing the Clinical Relevance of Patient-Reported Outcomes Changes?
-
Challenges of Health Technology Assessment in Pluralistic Healthcare Systems
-
Are We Ready For A New Approach To Comparing Coverage And Reimbursement Policies For Medical Nutrition In Key Markets
Health Technology Assessment
-
Is IQWiG's 15% Threshold Universally Applicable in Assessing the Clinical Relevance of Patient-Reported Outcomes Changes?
-
Challenges of Health Technology Assessment in Pluralistic Healthcare Systems
-
Designing and Implementing Deliberative Processes for Health Technology Assessment: Joint HTAi/ISPOR Task Force Report
Methodological & Statistical Research
Patient Centered Research
-
Accounting For Preference Heterogeneity In Discrete-Choice Experiments
-
Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions - Report of the ISPOR Stated Preference Research Special Interest Group
-
Defining Patient Engagement in Research: Results of a Systematic Review and Analysis
Real World Data & Information Systems
-
Improving Transparency to Build Trust in Real-World Secondary Data Studies - Real-World Evidence Transparency Initiative
-
Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness
-
Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0
Specialized Treatment Areas
-
Are We Ready For A New Approach To Comparing Coverage And Reimbursement Policies For Medical Nutrition In Key Markets
-
Being Precise About Precision Medicine: Report of the ISPOR Personalized Precision Medicine Special Interest Group
-
Medical Nutrition Terminology and Regulations in the United States and Europe